Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mawson Infrastructure Group Inc. Director's Dealing 2021

Mar 17, 2021

35202_dirs_2021-03-16_690132f5-f9cd-45c6-9678-e240c75c0756.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2021-03-09

Reporting Person: WILSON LIAM DANIEL (Chief Operating Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 52677 Direct